FOX 2 A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in pre-clinical studies for treating pancreatic cancer. Asfar Azmi, Ph.D., scientist, director of the Pancreatic Cancer Research Initiative and member of the Molecular Therapeutics Research Program at Karmanos, joined FOX 2 to talk about this new discovery, what it means for patients, and how he, his team, and other Karmanos colleagues are studying this disease. Dr. Azmi also shar...